Back to search

University of Crete (UOC)

Ο ρόλος των πλασμακυτταροειδών δενδριτικών κυττάρων στην επαγωγή ανοχής σε ασθενείς με ρευματοειδή αρθρίτιδα

Abstract

dc:description

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune diseasecharacterized by synovial inflammation, which is orchestrated by both innate andadaptive immune responses. Major hallmarks of autoimmunity in this disease includethe appearance of serum autoantibodies and the persistent activation of self-reactiveCD4+ cells. Although therapeutic strategies targeting cytokines and B or T cells havehad a major clinical impact, disease in many patients remains refractory to currentbiologic interventions, and for patients who show a response to therapy, trueremission associated with reestablishment of immune tolerance is rare. This hasincreased the interest in exploring strategies to reestablish immune tolerance andprovide longterm disease suppression.Dendritic cells (DCs) are professional antigenpresenting cells (APCs) that can induceeither immunity or tolerance. Myeloid DCs and plasmacytoid DCs represent the 2major subsets of DCs, with human plasmacytoid DCs defined asCD45+CD123+CD303+CD11c- cells and myeloid DCs defined asCD45+CD1a+CD11c+CD1c+ cells. Although both subsets exhibit a functionalplasticity in directing T cell responses, current evidence supports a predominant roleof plasmacytoid DCs in the maintenance of tolerance through the expansion/inductionof Treg cells. To date, two major subsets of Treg cells have been described: thymusderivedFoxp3+ Treg cells and adaptive interleukin-10 (IL-10)–producing Treg cells(Tr1 cells) generated in the peripheral blood.The importance of Treg cells in the maintenance of tolerance is highlighted by thedevelopment of spontaneous multiorgan autoimmunity following Treg cell deletion inrodents. In humans, reduced numbers of Treg cells and impaired function of Tregcells have been reported in patients with autoimmune diseases such as rheumatoidarthritis (RA), systemic lupus erythematosus, and multiple sclerosis. The molecularpathways involved in prompting plasmacytoid DCs to promote Treg cell developmentare not fully understood. Expression of the indoleamine 2,3-dioxygenase (IDO)enzyme by plasmacytoid DCs is thought to play a significant role in plasmacytoidDC–mediated Treg cell induction.Whether human DCs exploit similar mechanisms of Treg cell induction that mightfacilitate reestablishment of tolerance in a disease setting remains to be seen.Cytokine-directed therapy may have an impact on Treg cell function. Thus, Treg cellsin patients with active RA are functionally defective. Anti–tumor necrosis factor α (anti-TNFα) therapy reverses this defect, through conversion of naive T cells intoFoxp3+ Treg cells. Whether therapy may also have an impact on DCs, in terms ofchanging their effects on Treg cells, has not been explored.Herein, we present findings demonstrating that plasmacytoid DCs isolated frompatients with RA whose disease is in remission induce an additional, distinctpopulation of Treg cells, Tr1 regulatory cells, in a manner that is dependent on thepresence of IDO. Unlike the previously described anti-TNFα–induced Treg cells, thispopulation of genuine Tr1 cells does not express Foxp3 but, instead, secretes highlevels of IL-10. Most notably, these cells suppress the proliferation of autologousnaive CD4+ cells, in a dose-dependent manner.Finally, we studied how IL-21 cytokine effects on the function of pDCs, given thatIL-21 is found in high levels at the periphery of autoimmune diseases such assystemic erythematosus lups (SLE). IL-21 is an immunomodulatory cytokine that isimplicated in the pathogenesis of autoimmune diseases, by promoting B cellsdifferentiation, or by affecting Th17 and Tregs function. Dendritic cells are potentialregulators of immune responses, since mature dendritic cells promote autoimmunity,while immature dendritic cells promote tolerance. Thus, we studied the potential ofdendritic cells matured in the presence of IL-21 to affect on the activation andproliferation of naïve T cells.Our results suggest that dendritic cells matured in the presence of IL-21 significantlypromote the proliferation of allogeneic CD4+CD25- T cells, when IL-21 is presentduring the activation of T cells. This increased proliferation correlates well with highlevels of IFN-γ and TNF-α. Together our results highlight the intrinsic ability of pDCsto regulate T cell responses in an autoimmune setting in humans and further supportthe use of pDCs as a potential therapeutic modality for autoimmune diseases andtransplantation.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kavousanaki, Melina
  • Καβουσανάκη, Μελίνα

Subjects

dc:subject × 14

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28190

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kavousanaki, Melina; Καβουσανάκη, Μελίνα. Ο ρόλος των πλασμακυτταροειδών δενδριτικών κυττάρων στην επαγωγή ανοχής σε ασθενείς με ρευματοειδή αρθρίτιδα. University of Crete (UOC), 2012. http://hdl.handle.net/10442/hedi/28190